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Abstract 27 
Vascular endothelial function is declines with aging and is associated with an 28 
increased risk of cardiovascular disease. Lifestyle modification, particularly aerobic exercise 29 
and dietary adjustment, has a favorable effect on vascular aging. Curcumin, is a major 30 
component of turmeric, with known anti-inflammatory and anti-oxidative effects. We 31 
investigated the effects of curcumin ingestion and aerobic exercise training on flow-mediated 32 
dilation as an indicator endothelial function in postmenopausal women. A total of 32 33 
postmenopausal women were assigned to 3 groups: control, exercise, and curcumin groups. 34 
The curcumin group ingested curcumin orally for 8 weeks. The exercise group underwent 35 
moderate aerobic exercise training for 8 weeks. Before and after each intervention, 36 
flow-mediated dilation was measured. No difference in baseline flow-mediated dilation or 37 
other key dependent variables were detected among the groups. Flow-mediated dilation 38 
increased significantly and equally in the curcumin and exercise groups, whereas no changes 39 
were observed in the control group. Our results indicated that curcumin ingestion and aerobic 40 
exercise training can increase flow-mediated dilation in postmenopausal women, suggesting 41 
that both can potentially improve the age-related decline in endothelial function. 42 
 43 
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1. Introduction 47 
 Arterial endothelial dysfunction has been associated with cardiovascular morbidity 48 
and mortality [1]. Flow-mediated dilation (FMD), which is an index of endothelial function 49 
[2], is progressively impaired with age [3,4]. In women, the age-associated decline in 50 
endothelial function is enhanced during menopause because of the estrogen deficiency [5,6], 51 
and postmenopausal women are at a higher risk of cardiovascular disease [7]. Thus, slowing 52 
the decline of endothelial function in postmenopausal women could have potential health 53 
benefits. We and other groups have reported that aerobic exercise training enhances 54 
endothelial function [8-10]. Lifestyle modification is a desirable way to prevent or treat 55 
endothelial dysfunction without the need for pharmaceutical intervention. 56 
 57 
 58 
 Vascular inflammation and oxidative stress play important roles in development of 59 
vascular endothelial dysfunction and cardiovascular disease [11]. Previous studies have 60 
demonstrated that increased production of pro-inflammatory cytokines and reactive oxygen 61 
species in the aging vessel results in endothelial dysfunction [12,13]. Therefore, following an 62 
anti-inflammatory or anti-oxidative diet may help counteract the effects of aging on blood 63 
vessel. Curcumin, a polyphenol molecule extracted from turmeric, is a commonly used spice 64 
and a yellow pigment. Curcumin regulate biochemical and molecular pathway by modulating 65 
several molecular targets including transcription factors, cytokines, enzymes, and genes 66 
regulating cell proliferation and apoptosis [14-16]. In addition to the anti-inflammatory and 67 
anti-oxidative effects of curcumin [17,18], is has been associated with the protection against 68 
cardiovascular disease [19]. However, the effect of curcumin on endothelial function remains 69 
unclear. 70 
 71 
 72 
We hypothesized that, similar to exercise, curcumin ingestion could improve 73 
endothelial function. The objective of the present study was to determine the effect of 74 
curcumin ingestion and the effect of exercise training on endothelial function. We therefore 75 
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investigated endothelial function as measured by the FMD in postmenopausal women before 76 
and after 8 weeks of curcumin ingestion or exercise training intervention.  77 
 78 
 79 
2. Methods and materials 80 
2.1 Subjects A total of 32 healthy, sedentary postmenopausal women (amenorrhea 81 
for at least 2 years) participated in the study. Subjects were assigned to one of the following 82 
intervention groups: control group (n = 10), curcumin group (n = 11), and exercise training 83 
group (n = 11). Subjects were nonsmokers, nonobese, and free of cardiovascular disease as 84 
assessed by medical history. None of the subjects were taking cardiovascular-acting 85 
medications or hormone replacement therapy. All potential risks and associated with the 86 
study were explained to the subjects, and they gave their written informed consent for 87 
participation in the study. All procedures were reviewed and approved by the ethical 88 
committee of the University of Tsukuba. 89 
 90 
 91 
2.2 Experimental protocol All experiments were performed in the morning after a 92 
12-h overnight fast. Subjects abstained from alcohol and caffeine for at least 12 h and did not 93 
exercise for at least 24 h before beginning the experiment to avoid the potential acute effects 94 
of exercise. Measurements were taken in a quiet, temperature-controlled room (24–26°C). 95 
After a resting period of at least 20 min, FMD, arterial blood pressure, and blood 96 
biochemistry were determined. After these measurements, peak oxygen consumption 97 
(V
．
O2peak) was measured during incremental cycle ergometer exercise.  98 
 99 
 100 
2.3 Curcumin ingestion Subjects in the curcumin group ingested 6 pills (150 mg 101 
total) of curcumin per day [20,21], which supplies 25 mg of highly absorptive curcumin 102 
dispersed with colloidal nanoparticles (Theracurmin; Theravalues Corporation, Tokyo) [22]. 103 
Supplementary curcumin was administered orally for 8 weeks. All subjects were instructed 104 
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not to alter their dietary habits during the intervention period.  105 
 106 
 107 
2.4 Exercise training Subjects in the exercise group underwent aerobic exercise 108 
training more than 3 days per week (2-3 supervised sessions and additional home-based 109 
training) for 8 weeks [23]. Initially, subjects performed cycling and walking 30 min/day at a 110 
relatively low intensity (60% of their individually determined maximal heart rate). As their 111 
exercise tolerance improved, the intensity and duration of aerobic exercise were increased to 112 
40−60 min/day at an intensity of 70−75 % of the maximal heart rate. Subjects in the control 113 
and curcumin groups were instructed not to change their level of physical activity. 114 
 115 
 116 
2.5 Measurements  117 
2.5.1 FMD. Brachial artery FMD was assessed noninvasively by using an ultrasound 118 
system (UNEXEF18G, Unex, Nagoya, Japan) as previously described [24]. Briefly, 119 
high-resolution ultrasound with a 10 MHz linear array transducer was used to obtain a 120 
longitudinal image of the right brachial artery in the cubital region at the baseline and then 121 
continuously from 30 s prior to 2 min or more after the release of suprasystolic pressure (50 122 
mmHg above systolic blood pressure) maintained for 5 minutes of the right forearm. The 123 
diameter at the same point of the artery was monitored continuously, and the maximal 124 
dilatation after deflation was recorded. FMD was calculated as the percentage change in 125 
brachial artery diameter in response to the forearm reactive hyperemic stimulus. FMD was 126 
calculated as follows:  127 
(Maximal diameter – baseline diameter) × 100/baseline diameter 128 
 129 
 130 
2.5.2 Arterial blood pressure. Arterial blood pressure and heart rate at rest were 131 
determined in the supine position using an automated device (formPWV/ABI, Colin Medical 132 
Technology, Komaki, Japan) [23]. 133 
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 135 
2.5.3 Blood chemistry. A blood sample was collected from the antecubital vein after 136 
overnight fasting. Serum of cholesterol and triglyceride and plasma of glucose were 137 
determined using standard enzymatic techniques [25]. 138 
 139 
 140 
2.5.4 Peak oxygen consumption. V
．
O2peak was measured during incremental cycle 141 
ergometer exercise by using online computer-assisted circuit spirometry (AE280, Minato 142 
Medical Science, Osaka, Japan) as we previously reported [23]. All subjects underwent an 143 
incremental exercise test (2 min at 40 W, followed by 20 W increases every 2 min) until 144 
volitional exhaustion. V
．
O2peak was defined as the highest V
．
O2 recorded during the test. Heart 145 
rate and rating of perceived exertion were recorded throughout the exercise. 146 
 147 
 148 
2.6 Statistical analyses. The effects of each intervention on the outcomes 149 
measured were determined by repeated measures analysis of variance. If a significant effect 150 
was detected, specific mean comparisons were performed to determine the significance of 151 
each intervention. In the case of a significant F-value, a post-hoc test (Bonferroni test) was 152 
used to identify significant differences among mean values. All data are reported as means ± 153 
SD. Statistical significance was set a priori at P < 0.05 for all comparisons. 154 
 155 
 156 
3. Results 157 
 The compliance/adherence to curcumin ingestion in the curcumin group was 97.6 ± 158 
2.8%. No adverse effects of curcumin were reported. In the exercise training group, the 159 
average frequency and duration of the exercise training was 4.5 ± 1.4 days/week and 48 ± 23 160 
min/day. There were no drop-outs in either group. 161 
 162 
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 163 
Table 1 shows the baseline characteristics of the study participants. There were no 164 
group differences in age, height, body weight, body mass index, total cholesterol, 165 
high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, 166 
triglyceride, glucose, or V
．
O2peak between the groups at the start of the study. HDL cholesterol 167 
levels increased significantly in the exercise group (P < 0.05). There were no significant 168 
changes in body weight, body mass index, total cholesterol, LDL cholesterol, triglyceride and 169 
glucose levels in any of the groups. V
．
O2peak in the exercise group increased significantly after 170 
the intervention (P < 0.05). 171 
 172 
 173 
3.1 Heart rate and blood pressure 174 
 As shown in Table 2, no statistically significant differences in the baseline 175 
hemodynamic parameters at rest were detected among the groups before the intervention. 176 
After 8 weeks of intervention, systolic blood pressure decreased in the exercise and curcumin 177 
groups (P < 0.05). Heart rate and diastolic blood pressure did not change in any of the groups. 178 
 179 
 180 
3.2 FMD 181 
 No significant difference in the baseline FMD was detected among the groups (Fig. 182 
1). After 8 weeks of intervention, FMD increased significantly in the exercise and curcumin 183 
groups, whereas no significant change in FMD was detected in the control group. The change 184 
in FMD was significantly greater in the exercise and the curcumin groups than in the control 185 
group (Fig. 2). The differences in FMD changes between the exercise and curcumin groups 186 
were not statistically significant (Fig. 2). 187 
 188 
 189 
4. Discussion 190 
 The present study showed that regular ingestion of curcumin or regular aerobic 191 
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exercise training significantly improved endothelial function. The magnitude of improvement 192 
in endothelial function to the same extent, suggesting that curcumin may prevent the 193 
age-associated decline in endothelial function in postmenopausal women. 194 
 195 
 196 
 Curcumin, a polyphenolic derivative of turmeric, is widely cultivated in Asia and is 197 
commonly used as a spice to add flavor and yellow, coloring to food. Curcumin is known to 198 
anti-inflammatory and anti-oxidant effects in addition to acting as an anti-carciogenic and 199 
neuroprotective agent [26-28]. Recent studies have reported a beneficial effect of curcumin 200 
on the cardiovascular system, suggesting its potential as a therapeutic agent for the treatment 201 
of cardiovascular disease and endothelial dysfunction [19]. In this study, we showed an 202 
improvement in endothelial function after 8 weeks of the curcumin ingestion in 203 
postmenopausal women. The magnitude of the improvement achieved by curcumin treatment 204 
was comparable to that obtained with exercise. Therefore, regular ingestion of curcumin 205 
could be a preventive measure against cardiovascular disease in postmenopausal women. 206 
Furthermore, our results suggest that curcumin may be a potential alternative treatment for 207 
patients who are unable to exercise. 208 
 209 
 210 
Our hypothesis that curcumin ingestion may improve endothelial function in a 211 
similar manner as exercise was proven in the present study, as shown in the significant and 212 
comparable increase in FMD after 8 weeks of curcumin ingestion and exercise training. 213 
Regular aerobic exercise improves enhanced endothelial function, which has been associated 214 
with increased nitric oxide (NO) bioavailability [9,29]. Therefore, the exercise-induced 215 
endothelial function improvement in our study could have been mediated by an increase in 216 
NO bioavailability. However, the mechanism responsible for the curcumin ingestion induced 217 
improvement in endothelial function is unclear. Curcumin exerts anti-inflammatory and 218 
anti-oxidative effects by inhibiting tumor necrosis factor-alpha (TNF-α) [30], suggesting that 219 
its effect on endothelial function may be mediated by the suppression of inflammation and/or 220 
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oxidative stress via downregulation of TNF-α. However, TNF-α levels were mot assessed in 221 
this study. Further studies are warranted to clarify the mechanism undeerlying the effect of 222 
curcumin on endothelial function. 223 
 224 
 225 
In our previous study, we investigated the effect of exercise training and curcumin 226 
ingestion on central arterial hemodynamics, i.e., wave reflection and central blood pressure 227 
[21]. Wave reflection and central blood pressure did not improve with exercise training alone 228 
or curcumin ingestion alone, whereas these parameters improved in response to the 229 
combination of exercise training with curcumin ingestion. However, in the present study, we 230 
investigated the effect of curcumin on endothelial function as measured by FMD, and 231 
demonstrated for the first time that curcumin ingestion alone increased FMD, similar to the 232 
effect of exercise demonstrated previously. The effect of the combination of exercise training 233 
with curcumin ingestion on vascular endothelial function were not assessed in this study and 234 
should be addressed in future studies in comparison to the effect of each agent alone. 235 
 236 
 237 
The present study had some limitations. First, this study was conducted with a 238 
small sample size in each group. However, the power calculation indicated that the number of 239 
subjects was sufficient to establish statistical significance. Furthermore, this study focused 240 
only on postmenopausal women. Thus, the findings of this study cannot be generalized to 241 
other populations, such as men and young women. Second, the present study measured only 242 
FMD as an index of endothelial function. We did not measure any biomarkers of 243 
inflammation and oxidative stress, plasma curcumin concentration, or endothelial function 244 
using different indexs. Further studies are needed to clarify the mechanism underlying the 245 
effect of curcumin on vascular endothelial function. Third, analysis of the baseline 246 
characteristics of the participants and the baseline FMD suggest that the subjects in the 247 
exercise group showed overall better before the start of the study. Although there were no 248 
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significant differences in any of the variables among the groups before the intervention, small 249 
differences in baseline values might have biased the results. 250 
 251 
 252 
 In conclusion, we examined the effect of curcumin ingestion and exercise training 253 
on endothelial function in postmenopausal women and found that regular curcumin ingestion 254 
and exercise improve endothelial function. These findings suggest that curcumin could be 255 
developed as a therapeutic strategy for the treatment of cardiovascular disease similar to 256 
exercise training in postmenopausal women. 257 
 258 
 259 
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Figure legends 351 
 352 
Figure 1. FMD before and after intervention. Data are expressed as means ± SD. *P < 0.05 353 
before vs. after intervention. 354 
 355 
Figure 2. Changes in FMD in response to intervention. Data are expressed as means ± SD. *P 356 
< 0.05 vs. control group. 357 
 358 
 359 
 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
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 369 
 370 
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 373 
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Table1. Baseline characteristics of subjects 
 
 
Values are means ± SD. BMI; body mass index, HDL Cholesterol; high-density lipoprotein cholesterol, LDL Cholesterol; low-density lipoprotein cholesterol, V
．
O2peak; 
peak oxygen consumption. 
*P < 0.05 vs. before intervention. A main time and group effect overall by repeated-measures ANOVA. 
 
 
Control (n = 10) 
 
Exercise (n = 11) 
 
Curcumin (n = 11)   P  
  Before   After   Before   After   Before   After   Group Time Time×Group 
Age, years 64 ± 6 
     
59 ± 5 
     
60 ± 6 
   
    NS     
Height, cm 154 ± 6 
     
154 ± 4 
     
155 ± 8 
     
NS 
  
Weight, kg 51 ± 2 
 
51 ± 2 
 
54 ± 2 
 
54 ± 2 
 
54 ± 3 
 
54 ± 3 
 
NS NS NS 
BMI, kg/m 21.5 ± 1.0 
 
21.6 ± 1.0 
 
22.7 ± 1.0 
 
22.6 ± 1.0 
 
22.5 ± 1.0 
 
22.7 ± 1.0 
 
NS NS NS 
Total Cholesterol, mmol/l 6.1 ± 0.5 
 
6.3 ± 0.5 
 
5.4 ± 0.6 
 
5.7 ± 0.6 
 
6.3 ± 0.7 
 
6.6 ± 0.5 
 
NS 0.005 NS 
HDL Cholesterol, mmol/l 1.7 ± 0.4 
 
1.7 ± 0.3 
 
1.7 ± 0.3 
 
1.9 ± 0.3* 1.6 ± 0.5 
 
1.7 ± 0.5 
 
NS 0.010 NS 
LDL Cholesterol, mmol/l 3.8 ± 0.6 
 
3.9 ± 0.4 
 
3.2 ± 0.4 
 
3.5 ± 0.6 
 
3.8 ± 0.7 
 
4.0 ± 0.7 
 
NS 0.027 NS 
Triglyceride, mmol/l 1.4 ± 0.6 
 
1.3 ± 0.4 
 
1.0 ± 0.6 
 
0.9 ± 0.4 
 
1.9 ± 0.9 
 
1.7 ± 0.1 
 
NS NS NS 
Glucose, mmol/l 5.3 ± 0.4 
 
5.3 ± 0.4 
 
4.9 ± 0.4 
 
4.9 ± 0.3 
 
5.1 ± 1.1 
 
5.4 ± 1.6 
 
NS NS NS 
V
．
O2peak, ml/kg/min 22.9 ± 1.4   22.5 ± 1.1   25.3 ± 1.2   27.3 ± 1.2* 21.9 ± 0.7   21.9 ± 0.8   NS NS 0.024 
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Table 2. Hemodynamics parameter before and after intervention. 
Values are means ± SD. SBP; systolic blood pressure, DBP; diastolic blood pressure  
*P < 0.05 vs. before intervention. A main time and group effect overall by repeated-measures ANOVA. 
 
 
 
 
 
 
 
Control (n = 10) 
 
Exercise (n = 11) 
 
Curcumin (n = 11)   P value 
  Before   After   Before   After   Before   After 
 
Group Time Time×Group 
Heart rate, beats/min 62 ± 6 
 
64 ± 11 
 
61 ± 6 
 
57 ± 5 
 
61 ± 8 
 
59 ± 7 
 
NS NS NS 
SBP, mmHg 112 ± 12 
 
113 ± 11 
 
112 ± 10 
 
107 ± 10* 
 
122 ± 17 
 
116 ± 15* NS 0.003 0.025 
DBP mmHg 69 ± 5   69 ± 6   71 ± 8   69 ± 9   72 ± 12   69 ± 11   NS NS NS 
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